Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Generic Industry Wants More As J&J Loosens Grip On Darunavir Patents

This article was originally published in The Pink Sheet Daily

Executive Summary

J&J’s gesture to free up patents in least developed countries and Sub-Saharan Africa is greeted with mixed responses, with some calling it pragmatic while others say it is limited in scope.

Advertisement

Related Content

Back To The Future: Gilead Signs Up Four Indian Companies To License Late-stage AIDS Therapies
J&J Worldwide Chairman Paul Stoffels On Precompetitive Alliances, Patent Pools And Tropical Drugs: An Interview With PharmAsia News

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS073570

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel